Ophthalmic Gene Therapy: A 1.5-Hour Deep Dive for Biotech Professionals
A concise yet comprehensive exploration of ophthalmic gene therapy, covering genetic mechanisms, delivery systems, clinical applications, and future trends for biotech professionals.
...
Share
Fundamentals of Inherited Retinal Diseases and Gene Therapy Vectors
Unit 1: Inherited Retinal Diseases (IRDs): Genetic Basis
Intro to Inherited IRDs
Mutations in IRDs
Molecular Mechanisms
Unit 2: Gene Therapy Vectors: An Overview
Gene Therapy Intro
AAV Vectors: The Workhorse
Lentiviral Vectors
Adenoviral Vectors
Unit 3: Vector Properties: Tropism, Immunogenicity, and Payload
Vector Tropism
Immunogenicity
Payload Capacity
Delivery Methods, Clinical Applications, and Approved Therapies
Unit 1: Gene Therapy Delivery Methods
Subretinal Delivery
Intravitreal Delivery
Comparing Delivery Methods
Unit 2: Clinical Applications and Approved Therapies
Luxturna: A Success Story
Luxturna: Safety Profile
Stargardt Disease Therapies
Usher Syndrome Therapies
Other IRD Therapies
Clinical Trial Design
Future Directions
Emerging Technologies, Manufacturing, and Ethical Considerations
Unit 1: Gene Editing Technologies
CRISPR-Cas9 Overview
CRISPR for IRDs
Base Editing Explained
Minimizing Off-Target Effects
Unit 2: Manufacturing and Quality Control
Scaling Up Production
Quality Control
Regulatory Landscape
Cost-Effectiveness
Unit 3: Ethical Considerations
Patient Selection
Informed Consent